Darvon Compound-65 (aspirin / caffeine / propoxyphene) Drug Interactions
A total of 1336 drugs (7207 brand and generic names) are known to interact with Darvon Compound-65 (aspirin / caffeine / propoxyphene).
- 662 major drug interactions (4004 brand and generic names)
- 633 moderate drug interactions (3039 brand and generic names)
- 41 minor drug interactions (164 brand and generic names)
Check for interactions with Darvon Compound-65 (aspirin / caffeine / propoxyphene)
Common medications checked in combination with Darvon Compound-65 (aspirin / caffeine / propoxyphene)
- Ambien CR (zolpidem)
- Cerefolin NAC (multivitamin)
- Crestor (rosuvastatin)
- Flexeril (cyclobenzaprine)
- Forteo (teriparatide)
- hydrochlorothiazide
- Levothroid (levothyroxine)
- Levoxyl (levothyroxine)
- lisinopril
- Metanx (multivitamin)
- metoprolol
- Mirapex (pramipexole)
- multivitamin
- Niaspan (niacin)
- omeprazole
- Plavix (clopidogrel)
- Toprol-XL (metoprolol)
- Vitamin C (ascorbic acid)
- Zetia (ezetimibe)
- Zolpimist (zolpidem)
Darvon Compound-65 (aspirin / caffeine / propoxyphene) alcohol/food Interactions
There are 6 alcohol/food interactions with Darvon Compound-65 (aspirin / caffeine / propoxyphene)
Darvon Compound-65 (aspirin / caffeine / propoxyphene) disease Interactions
There are 34 disease interactions with Darvon Compound-65 (aspirin / caffeine / propoxyphene) which include:
- Coagulation
- Cardiac Disease
- Hypertension
- Liver Disease
- Seizure Disorders
- Pud
- Impaired Gi Motility
- Infectious Diarrhea
- Liver Disease
- Prematurity
- Renal Dysfunction
- Asthma
- Acute Alcohol Intoxication
- Drug Dependence
- Hypotension
- Intracranial Pressure
- Respiratory Depression
- Gi Toxicity
- Renal Dysfunction
- Reye's Syndrome
- Cardiotoxicity
- Psychiatric Disorders
- Renal Dysfunction
- Gerd
- Adrenal Insufficiency
- Biliary Spasm
- Hypothyroidism
- Seizure Disorders
- Urinary Retention
- Arrhythmias
- Anemia
- Dialysis
- G-6-Pd Deficiency
- Hepatotoxicity
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
